Ireland vs SEAR: Estimated antiretroviral therapy coverage among people living with HIV
Ireland
91.0%
in 2023
SEAR
22.0%
in 2025
Ireland rank
15th
SEAR rank
12th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Ireland
- SEAR
How they compare
Ireland currently reports 91.0% against 22.0% in SEAR, a difference of 69.0%.
That makes Ireland's figure about 4.1 times SEAR's.
Across all 24 years both countries report, Ireland has been ahead every year.
Ireland ranks 15th and SEAR ranks 12th of 143 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.4% | 2.2% | 51.2% | Ireland |
| 2010s | 72.3% | 12.3% | 60.0% | Ireland |
| 2020s | 87.0% | 19.8% | 67.2% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Ireland or SEAR?
- Ireland, at 91.0% against 22.0% in SEAR as of 2023.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Ireland and SEAR?
- 69.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and SEAR?
- 24 years are reported by both, from 2000 to 2023.
- How do Ireland and SEAR rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Ireland ranks 15th and SEAR ranks 12th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.